Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13)

Thumbnail
Göster/Aç
Tarih
2020
Yazar
Ugurel, Osman Mutluhan
Mutlu, Ozal
Sariyer, Emrah
Kocer, Sinem
Ugurel, Erennur
Inci, Tugba Gul
Ata, Oguz
Turgut-Balik, Dilek
Üst veri
Tüm öğe kaydını göster
Özet
SARS-CoV-2 has caused COVID-19 outbreak with nearly 2 M infected people and over 100K death worldwide, until middle of April 2020. There is no confirmed drug for the treatment of COVID-19 yet. As the disease spread fast and threaten human life, reposition
Bağlantı
https://doi.org/10.1016/j.ijbiomac.2020.09.138
http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2277
Koleksiyonlar